TY - JOUR T1 - A novel fragment derived from the beta chain of human fibrinogen, beta43-63, is a potent inhibitor of activated endothelial cells in vitro and in vivo. JO - Br J Cancer PY - 2010/02/02 AU - Krajewska E AU - Lewis CE AU - Chen Y-Y AU - Welford A AU - Tazzyman S AU - Staton CA ED - DO - DOI: 10.1038/sj.bjc.6605495 VL - 102 IS - 3 SP - 594 EP - 601 Y2 - 2025/07/05 ER -